Robert Lorne Hopfner - Net Worth and Insider Trading

Robert Lorne Hopfner Net Worth

The estimated net worth of Robert Lorne Hopfner is at least $98 Million dollars as of 2024-04-23. Robert Lorne Hopfner is the Director of Vaxcyte Inc and owns about 1,405,418 shares of Vaxcyte Inc (PCVX) stock worth over $87 Million. Robert Lorne Hopfner is the Director of Inozyme Pharma Inc and owns about 1,571,741 shares of Inozyme Pharma Inc (INZY) stock worth over $7 Million. Robert Lorne Hopfner is also the Director of Rallybio Corp and owns about 2,267,411 shares of Rallybio Corp (RLYB) stock worth over $4 Million. Details can be seen in Robert Lorne Hopfner's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert Lorne Hopfner has not made any transactions after 2023-08-01 and currently still holds the listed stock(s).

Transaction Summary of Robert Lorne Hopfner

To

Robert Lorne Hopfner Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert Lorne Hopfner owns 3 companies in total, including Inozyme Pharma Inc () , Vaxcyte Inc () , and Rallybio Corp () .

Click here to see the complete history of Robert Lorne Hopfner’s form 4 insider trades.

Insider Ownership Summary of Robert Lorne Hopfner

Ticker Comapny Transaction Date Type of Owner
Inozyme Pharma Inc 2023-08-01 director & 10 percent owner
Vaxcyte Inc 2021-02-10 director
Rallybio Corp 2021-08-02 director

Robert Lorne Hopfner Latest Holdings Summary

Robert Lorne Hopfner currently owns a total of 3 stocks. Among these stocks, Robert Lorne Hopfner owns 1,405,418 shares of Vaxcyte Inc (PCVX) as of February 10, 2021, with a value of $87 Million and a weighting of 88.56%. Robert Lorne Hopfner owns 1,571,741 shares of Inozyme Pharma Inc (INZY) as of August 1, 2023, with a value of $7 Million and a weighting of 7.24%. Robert Lorne Hopfner also owns 2,267,411 shares of Rallybio Corp (RLYB) as of August 2, 2021, with a value of $4 Million and a weighting of 4.2%.

Latest Holdings of Robert Lorne Hopfner

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PCVX Vaxcyte Inc 2021-02-10 1,405,418 61.61 86,587,803
INZY Inozyme Pharma Inc 2023-08-01 1,571,741 4.51 7,080,693
RLYB Rallybio Corp 2021-08-02 2,267,411 1.81 4,104,241

Holding Weightings of Robert Lorne Hopfner


Robert Lorne Hopfner Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert Lorne Hopfner has made a total of 9 transactions in Vaxcyte Inc (PCVX) over the past 5 years, including 1 buys and 8 sells. The most-recent trade in Vaxcyte Inc is the sale of 378,698 shares on February 10, 2021, which brought Robert Lorne Hopfner around $10 Million.

According to the SEC Form 4 filings, Robert Lorne Hopfner has made a total of 6 transactions in Inozyme Pharma Inc (INZY) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Inozyme Pharma Inc is the acquisition of 833,333 shares on August 1, 2023, which cost Robert Lorne Hopfner around $4 Million.

According to the SEC Form 4 filings, Robert Lorne Hopfner has made a total of 1 transactions in Rallybio Corp (RLYB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Rallybio Corp is the acquisition of 576,923 shares on August 2, 2021, which cost Robert Lorne Hopfner around $8 Million.

Insider Trading History of Robert Lorne Hopfner

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert Lorne Hopfner Trading Performance

GuruFocus tracks the stock performance after each of Robert Lorne Hopfner's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert Lorne Hopfner is 11.11%. GuruFocus also compares Robert Lorne Hopfner's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert Lorne Hopfner within 3 months outperforms 6 times out of 8 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Robert Lorne Hopfner's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Robert Lorne Hopfner

Average Return

14.23%

Average return per transaction

Outperforming Transactions

50%

3 out of 6 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 5.51 11.11 -12.54 14.23 -27.97 -9.76
Relative Return to S&P 500(%) 3.62 8.11 -19.1 -5.93 -35.57 -22.09

Robert Lorne Hopfner Ownership Network

Ownership Network List of Robert Lorne Hopfner

No Data

Ownership Network Relation of Robert Lorne Hopfner


Robert Lorne Hopfner Owned Company Details

What does Inozyme Pharma Inc do?

Who are the key executives at Inozyme Pharma Inc?

Robert Lorne Hopfner is the director & 10 percent owner of Inozyme Pharma Inc. Other key executives at Inozyme Pharma Inc include COO Matthew Winton , See Remarks Henric Bjorn Bjarke , and director & 10 percent owner & See Remarks Axel Bolte .

Inozyme Pharma Inc () Insider Trades Summary

Over the past 18 months, Robert Lorne Hopfner made 4 insider transaction in Inozyme Pharma Inc () with a net purchase of 1,833,697. Other recent insider transactions involving Inozyme Pharma Inc () include a net purchase of 833,333 shares made by Pivotal Bioventure Partners Fund I G.p., L.p. , a net sale of 7,523 shares made by Douglas A Treco ,

In summary, during the past 3 months, insiders sold 7,523 shares of Inozyme Pharma Inc () in total and bought 0 shares, with a net sale of 7,523 shares. During the past 18 months, 7,523 shares of Inozyme Pharma Inc () were sold and 2,667,030 shares were bought by its insiders, resulting in a net purchase of 2,659,507 shares.

Inozyme Pharma Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Inozyme Pharma Inc Insider Transactions

No Available Data

Robert Lorne Hopfner Mailing Address

Above is the net worth, insider trading, and ownership report for Robert Lorne Hopfner. You might contact Robert Lorne Hopfner via mailing address: C/o Bay City Capital, Llc, 750 Battery Street, Suite 400, San Francisco Ca 94111.

Discussions on Robert Lorne Hopfner

No discussions yet.